Replies to post #7274 on Titan Pharmaceuticals Inc (TTNP)

[Doctor Detroit]

Anyone do the math on a 2018 launch of probuphine for chronic pain from the Braeburn presentation?

Assuming they were approved on December 31, 2018, I don't think they'd get priority review so that's one year for FDA review (2018) , and at least a year or so for the Phase III trials (2017)...so initiation of the trials could occur in 2016. This really could be an awesome year.

[Rentier]

Not that it matters much since Titan gets a cut of the action on that implant too.

What we really need now is to get over $5 so big funds can get in that can't or won't touch stuff sub $5.